Perceptions toward Performance Status Scale in the Management of Head‑and‑Neck Cancer Patients among Health‑Care Providers in Edo State, Nigeria

Authors

  • Olajumoke Babalola Departments of Family Dentistry and Oral and Maxillofacial Surgery, Faculty of Dentistry, College of Medical Sciences, University of Benin, Benin City, Edo State, Nigeria Author
  • Ekaniyere Benlance Edetanlen Departments of Family Dentistry and Oral and Maxillofacial Surgery, Faculty of Dentistry, College of Medical Sciences, University of Benin, Benin City, Edo State, Nigeria Author

DOI:

https://doi.org/10.60787/njgp.v18i2.37

Keywords:

score, performance status scale, neck cancer, medical practitioner, Head

Abstract

Background: The role of performance status scales (PSSs) are well documented globally in the management of cancer patients in the
developed countries but not in low‑income countries, mainly due to the lack of awareness. The aim of the present study is to assess
the level of awareness, knowledge, and practice of PSSs among medical physicians managing head‑and‑neck tumors in Edo state,
Nigeria.

Materials and Methods: This descriptive cross‑sectional study that recruited all physicians that manage head and neck in Edo
state between April 2019 and December 2019. Data were obtained with a self‑administered questionnaire, which was given to all who
participants that gave written informed consent. The statistical analysis was performed using the Statistical Package for the Social Sciences version 21 (IBM, Chicago, IL, USA).

Results: One hundred and six of the 110 randomly distributed questionnaires were retrieved, given a response rate of 96.4%. The male‑to‑female ratio was 2.4:1.0. The mean age was 33.3 ± 5.30 years, ranging from 25 to 46 years. Most of the respondents were within the age range of 31–40 years. Of the total 106 respondents, less than half (46.2%) had heard of PSS. More than two‑thirds (73.6%) of the respondents that are aware of PSS had poor general knowledge. More than half (53.8%) of the respondents answered that they have never used PSS in the course of managing head‑and‑neck cancer (HNC) patients. The age, gender, years of practice, type of specialty, and location of practice were not related to the knowledge of PSS by the respondents (P > 0.05), but only the awareness of PSS was related to knowledge of PSS (P = 0.02).

Conclusion: Most medical practitioners that manage HNC patients lack awareness and knowledge of PSSs, which reflected in poor utilization in the management of patients in routine practice.

Downloads

Download data is not yet available.

References

Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69‑90.

Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43‑66.

Boyle P, Bernard L. World Cancer Report 2008. Lyon, France: International Agency Research On Cancer; 2008.

Kreier A, Clifford G, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide. A systematic review. Cancer Epidemiol Biomarkers Prev 2005;14:467‑75.

Karnofsky DA, Abelmann WH, Craver LF, Burchenal JH. The use of the nitrogen mustards in the palliative treatment of carcinoma ‑ with

particular reference to bronchogenic carcinoma. Cancer 1948;1:634‑56.

Lansky SB, List MA, Lansky LL, Ritter‑Sterr C, Miller DR. The measurement of performance in childhood cancer patients. Cancer 1987;60:1651‑6.

Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agent in cancer. In: Macleod CM, editor. Evaluation of Chemotherapeutic Agent. New York, USA: Columba University Press; 1949.

Buccheri G, Ferrigno D, Tamburini M. Karnofsky and ECOG performance status scoring in lung cancer: A prospective, longitudinal study of 536 patients from a single institution. Eur J Cancer 1996;32A: 1135‑41.

Schag CC, Heinrich RL, Ganz PA. Karnofsky performance status revisited: Reliability, validity, and guidelines. J Clin Oncol 1984;2:187‑93.

Taylor AE, Olver IN, Sivanthan T, Chi M, Purnell C. Observer error in grading performance status in cancer patients. Support Care Cancer 1999;7:332‑5.

Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649‑55.

Albain KS, Crowley JJ, LeBlanc M, Livingston RB. Survival determinants in extensive‑stage non‑small‑cell lung cancer: The Southwest Oncology Group experience. J Clin Oncol 1991;9:1618‑26.

Kish L. Survey Sampling. New York: Wiley Inter‑Science Publication; 1965.

Brieley JD, Gospodarrowicz MK, Wittekind CH. TNM Atlas: Illustrated Guide to TNM Classification of Malignant Tumors. 8th ed. New York:

Wiley Blackwell; 2018.

Kimberlin CL, Winterstein AG. Validation and reliability of measurement instruments used in research. Am J Health Syst Pharm 2008;65:2276‑84.

Downloads

Published

2020-08-17

Issue

Section

Original Articles

How to Cite

1.
Babalola O, Edetanlen EB. Perceptions toward Performance Status Scale in the Management of Head‑and‑Neck Cancer Patients among Health‑Care Providers in Edo State, Nigeria. NJGP [Internet]. 2020 Aug. 17 [cited 2025 May 3];18(2):37-42. Available from: https://www.njgp.net.ng/index.php/home/article/view/37

Similar Articles

1-10 of 71

You may also start an advanced similarity search for this article.